Karman Holdings Inc.
KRMN
$62.48
+6.22%
Karman Holdings Inc. is a specialized aerospace and defense company that designs, tests, manufactures, and sells mission-critical systems for missile defense, hypersonics, and space programs. It operates as a key supplier and technology integrator within the defense industrial base, providing engineered solutions like payload protection, propulsion, and interstage systems for critical Department of Defense and space initiatives. The current investor narrative is heavily influenced by heightened geopolitical tensions, which are driving expectations for increased defense spending, particularly in hypersonics and missile defense, as evidenced by recent news headlines linking defense stock rallies to US-Iran conflict risks. However, the stock's recent volatility also reflects investor debate over its execution capabilities, cash flow generation, and valuation following its public listing in early 2025.…
KRMN
Karman Holdings Inc.
$62.48
Investment Opinion: Should I buy KRMN Today?
Rating: Hold. The core thesis is that Karman possesses a compelling long-term growth narrative in premium defense markets, but near-term financial deterioration and extreme valuation create an unacceptable risk/reward profile at the current price, warranting a sidelines stance.
Supporting this Hold rating are several conflicting data points: explosive 47.4% YoY revenue growth contrasts with a collapsing gross margin (16.5% in Q4) and deeply negative free cash flow (-$43.0M). The forward PS of ~6.6x suggests growth is being priced in more reasonably, but the trailing PS of 20.5x remains a massive premium to the industry. Analyst sentiment is overwhelmingly bullish, yet the stock's price action (-36.68% over 3 months) reflects a severe loss of momentum. The company is profitable (net margin of 5.7% in Q4) but the path to sustained, high-quality earnings is unclear.
The thesis would upgrade to a Buy if the stock falls further to price in more risk (e.g., below $50, aligning closer to a 4x forward PS) AND the company demonstrates gross margin stabilization above 25% and a credible path to positive free cash flow. It would downgrade to a Sell if QoQ revenue growth turns negative, cash burn accelerates, or the stock breaks below its 52-week low of $36.11. Relative to its own volatile history and premium sector multiples, the stock remains overvalued, pricing in perfection that recent operating results have failed to deliver.
Sign up to view all
KRMN 12-Month Price Forecast
The outlook is bifurcated between a promising long-term market position and alarming near-term financial metrics. The base case of volatile, cash-burning growth is most probable, leading to a neutral stance. Confidence is medium due to the extreme volatility in both operations and stock price. The stance would upgrade to bullish on clear evidence of margin recovery and a deceleration in cash burn. It would turn bearish if the next quarterly report shows further gross margin deterioration or an acceleration in revenue growth deceleration. The high short interest and recent sharp decline suggest the stock is in a 'show me' phase where promises must turn into sustainable financial results.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Karman Holdings Inc.'s 12-month outlook, with a consensus price target around $81.22 and implied upside of +30.0% versus the current price.
Average Target
$81.22
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$50 - $81
Analyst target range
Analyst coverage is limited but generally bullish, with 3 firms providing estimates and a clear pattern of institutional ratings available. The consensus sentiment leans positive, as evidenced by recent actions from multiple firms: Needham maintains a 'Buy', Baird an 'Outperform', Piper Sandler upgraded to 'Overweight', Keybanc an 'Overweight', Evercore ISI and RBC Capital 'Outperform', and Citigroup a 'Buy'. The sole bearish voice is BWS Financial, which maintains a 'Sell' rating. The average revenue estimate for the forward period is $1.457 billion, with a range from $1.365 billion to $1.515 billion. The target price range implied by analyst estimates is not explicitly provided in the data, but the revenue estimate range suggests a 10% band around the consensus, indicating moderate uncertainty. The high-end estimate of $1.515 billion likely assumes successful contract awards, seamless execution, and a resolution of cash flow challenges, leading to multiple expansions. The low-end estimate of $1.365 billion may factor in potential program delays, execution missteps, or continued cash burn pressuring the balance sheet. The recent mix of ratings—with one upgrade (Piper Sandler to Overweight) and no downgrades in the institutional data—suggests analyst sentiment has stabilized or improved slightly following the stock's sharp pullback, viewing the decline as a potential entry point for the long-term growth story.
Bulls vs Bears: KRMN Investment Factors
The bull case for Karman rests on its exposure to high-growth defense niches and explosive 47% revenue growth, supported by a bullish analyst community and a forward valuation that appears more reasonable. The bear case is powerfully grounded in deteriorating fundamentals: a catastrophic gross margin collapse, severe cash burn, and an extreme valuation premium that is unraveling amid a sharp technical breakdown. Currently, the bear side has stronger evidence due to the concrete, worsening financial metrics (cash flow, margins) that directly threaten the company's sustainability. The single most important tension in the investment debate is whether Karman can achieve the massive revenue scale implied by its forward PS (~$1.5B) before its cash runway expires and before margin volatility destroys investor confidence. The resolution of this execution vs. financial fragility dilemma will determine the stock's direction.
Bullish
- Explosive Revenue Growth: Q4 2025 revenue grew 47.4% year-over-year to $134.5 million, driven by strong demand in hypersonics and missile defense. This growth rate far exceeds typical aerospace & defense peers, justifying a premium valuation if sustained.
- Favorable Geopolitical Backdrop: Recent news highlights defense stock rallies tied to US-Iran tensions, directly supporting Karman's end-markets. The company's focus on missile defense and hypersonics positions it as a primary beneficiary of increased DoD spending in these priority areas.
- Strong Analyst Sentiment: Institutional analyst ratings are overwhelmingly positive, with firms like Needham (Buy), Baird (Outperform), and Piper Sandler (Overweight) endorsing the stock. Only one firm, BWS Financial, maintains a Sell rating, indicating broad institutional confidence in the long-term story.
- Attractive Forward Valuation: The forward Price-to-Sales ratio of ~6.6x (based on consensus revenue of $1.457B) represents a significant discount to the trailing PS of 20.5x. This implies the market has already priced in substantial growth de-risking, offering potential upside if execution meets estimates.
Bearish
- Severe Cash Burn: Trailing twelve-month free cash flow is deeply negative at -$43.0 million, with a price-to-cash-flow ratio of -437.7. This unsustainable burn rate necessitates external financing, diluting shareholders or increasing leverage from an already high debt-to-equity of 1.53.
- Gross Margin Collapse: Q4 2025 gross margin plummeted to 16.5% from 41.0% in Q3, indicating severe pricing pressure, unfavorable contract mix, or cost inflation. This extreme volatility undermines earnings predictability and raises questions about the company's pricing power and cost control.
- Intense Technical Downtrend: The stock is down 36.68% over 3 months and 20.51% over 1 month, severely underperforming the SPY by -40.82 and -30.49 points, respectively. This accelerating sell-off suggests a breakdown of the longer-term uptrend and a loss of investor confidence.
- Extreme Valuation Premium: Even after the sell-off, the trailing PS of 20.5x is a massive premium to the typical Aerospace & Defense sector range of 1.5x-4x. This demands flawless execution and hyper-growth for years to justify, leaving no room for error.
KRMN Technical Analysis
The stock is in a pronounced downtrend from its recent highs, having declined 36.68% over the past three months and 20.51% over the past month, sharply underperforming the SPY's gains of 4.14% and 9.98% over the same periods, respectively. Despite this severe short-term weakness, the 1-year price change of +81.07% indicates the stock is still in a longer-term uptrend from its base a year ago, though this positive momentum has decisively broken down. The current price of $65.73 sits approximately 44% above its 52-week low of $36.11 but 44% below its 52-week high of $118.38, positioning it in the lower-middle of its annual range and suggesting the speculative premium from its early 2026 rally has been largely erased. Recent momentum is decisively negative and accelerating to the downside, with the 1-month loss of 20.51% far exceeding the 3-month loss of 36.68% on a monthly run-rate basis, indicating selling pressure is intensifying. This sharp short-term decline starkly diverges from the strong 1-year performance, signaling a potential trend reversal or a deep correction as the stock digests its previous massive gains. The stock's relative strength versus the SPY is deeply negative at -30.49 over one month and -40.82 over three months, confirming it is in a severe downtrend irrespective of broader market conditions. Key technical support is at the 52-week low area near $36.11, while immediate resistance is at the recent breakdown level around $86-90 from early April. A breakdown below the $65 support level, which held in late April, could trigger a move toward the $50s, whereas a recovery above $90 would be needed to signal the downtrend is abating. The stock exhibits extreme volatility, as evidenced by its price swinging from a low near $58 in November 2025 to a high above $115 in January 2026; this wild price action, coupled with a short ratio of 4.96, indicates high speculative interest and potential for sharp, sentiment-driven moves in both directions.
Beta
—
—
Max Drawdown
-49.0%
Largest decline past year
52-Week Range
$38-$118
Price range past year
Annual Return
+59.1%
Cumulative gain past year
| Period | KRMN Return | S&P 500 |
|---|---|---|
| 1m | -24.3% | +8.6% |
| 3m | -21.4% | +6.7% |
| 6m | +4.2% | +9.8% |
| 1y | +59.1% | +26.6% |
| ytd | -18.7% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
KRMN Fundamental Analysis
Revenue growth is exceptionally strong but shows signs of sequential deceleration. For Q4 2025 (ending Dec 31), revenue was $134.5 million, representing a robust 47.4% year-over-year growth. However, examining the quarterly progression within 2025 reveals a moderating trend: Q1 revenue was $100.1 million, Q2 $115.1 million, Q3 $121.8 million, and Q4 $134.5 million. The quarter-over-quarter growth rate slowed from 15.0% in Q2 to 5.8% in Q3 and 10.4% in Q4, suggesting growth, while still high, may be plateauing from its initial post-IPO surge. The company is profitable on a net income basis but with thin and volatile margins. Q4 2025 net income was $7.7 million, yielding a net margin of 5.7%, a significant improvement from the net loss of $4.8 million in Q1 2025. Gross margin was 16.5% in Q4, a sharp contraction from the 41.0% gross margin reported in Q3 2025, indicating potential pricing pressure, mix shifts, or cost inflation. Operating margin for Q4 was a healthier 15.7%, but the disparity between gross and operating margin points to low cost of revenue but significant operating leverage, though the quarterly margin volatility raises questions about earnings quality and predictability. The balance sheet shows moderate leverage but concerning cash flow generation. The debt-to-equity ratio is 1.53, indicating a leveraged capital structure typical for capital-intensive industrials. More critically, the trailing twelve-month free cash flow is deeply negative at -$43.0 million, and the price-to-cash-flow ratio is an extreme -437.7, signaling the company is burning cash to fund operations and growth. The current ratio is strong at 3.29, providing good short-term liquidity, and return on equity is a modest 4.5%. The fundamental picture is one of a high-growth company investing heavily ahead of its cash generation, resulting in a fragile financial profile dependent on external financing or future contract awards to sustain operations.
Quarterly Revenue
$134492000.0B
2025-12
Revenue YoY Growth
+0.47%
YoY Comparison
Gross Margin
+0.16%
Latest Quarter
Free Cash Flow
$-43018228.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is KRMN Overvalued?
Given the company's positive but minimal net income (EPS of $0.0018), the primary valuation metric selected is the Price-to-Sales (PS) ratio, as the extreme trailing P/E of 557.5x is not meaningful. The trailing PS ratio is 20.5x, while the forward PS ratio, based on estimated revenue of $1.457 billion, implies a forward multiple of approximately 6.6x (market cap of $9.68B / $1.457B). The massive gap between trailing and forward PS indicates the market is pricing in tremendous revenue growth and significant margin expansion to justify the current valuation. Compared to the Aerospace & Defense industry, a trailing PS of 20.5x represents a substantial premium, as typical sector PS ratios often range from 1.5x to 4x for mature contractors. Karman's premium of several hundred percent is ostensibly justified by its exposure to high-growth end-markets like hypersonics and space, and its 47% revenue growth rate, but it also implies flawless execution and contract wins are already priced in. The EV/Sales multiple of 20.3x corroborates this rich sales-based valuation. Historically, the stock's own valuation has been volatile and is currently below its recent peaks. The PS ratio has ranged from a low of 43.5x in Q4 2024 to a high of 78.4x in Q3 2025, with the current 20.5x sitting near the lower end of this observed range. This de-rating suggests the market has tempered its growth expectations following the post-IPO surge, moving from peak optimism to a more cautious stance. However, even at this lower level, the valuation remains demanding and requires sustained hyper-growth to be sustained.
PE
557.5x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -230x~590x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
88.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are severe and center on cash burn and margin instability. The company is burning cash at a rate of -$43.0 million TTM, with a debt-to-equity ratio of 1.53, indicating dependence on external capital markets. The gross margin collapse from 41.0% to 16.5% in one quarter reveals extreme earnings volatility and potential lack of pricing power, making future profitability highly uncertain. Revenue, while growing, shows signs of sequential deceleration, raising execution risks as the company must nearly 11x its quarterly revenue run-rate to meet forward analyst estimates of $1.457 billion.
Market & Competitive Risks stem from its extreme valuation and speculative nature. Trading at a trailing PS of 20.5x—a premium of several hundred percent to sector peers—Karman is vulnerable to severe multiple compression if growth falters or investor sentiment shifts away from speculative growth stories. The stock's high short ratio of 4.96 and wild price swings (52-week range of $36.11 to $118.38) indicate it is a sentiment-driven, volatile instrument. While geopolitical news provides tailwinds, the company's fortunes are tied to specific DoD program awards, creating binary event risk.
Worst-Case Scenario involves a combination of a major contract delay, continued gross margin pressure, and a tightening capital market that limits its ability to fund operations. This could trigger a liquidity crisis, forced equity dilution at depressed prices, and a loss of analyst support. The realistic downside is significant: a retest of the 52-week low of $36.11, which would represent a decline of approximately 45% from the current price of $65.73. Given the stock's 42.99% max drawdown history and accelerating selling pressure, a move to the $40-$50 range in the next 12 months is a plausible adverse outcome.
FAQ
The key risks are, in order of severity: 1) Financial Risk: The company is burning cash at an unsustainable rate (-$43M TTM) with a leveraged balance sheet (Debt/Equity of 1.53), risking dilution or a liquidity crisis. 2) Operational Risk: Extreme gross margin volatility, with a collapse from 41% to 16.5% in one quarter, threatens profitability and business model credibility. 3) Valuation Risk: The stock trades at a huge premium to peers and is down 37% in 3 months, indicating vulnerability to further multiple compression if growth slows. 4) Execution Risk: The company must execute near-perfectly to hit the $1.5B revenue estimates that justify its forward multiple.
The 12-month forecast presents three scenarios. The Base Case (50% probability) sees the stock trading between $70 and $90, as the company meets growth estimates but continues to face margin and cash flow challenges. The Bull Case (25% probability) projects a rally to $100-$118 on contract wins and margin recovery. The Bear Case (25% probability) warns of a decline to $36-$55 if execution falters and cash burn forces dilution. The most likely outcome is the Base Case, which assumes the company grows but fails to resolve its fundamental financial weaknesses in the near term.
KRMN is overvalued on a trailing basis but may be fairly valued looking forward, assuming flawless execution. The trailing Price-to-Sales ratio of 20.5x is a massive premium to the Aerospace & Defense sector (typically 1.5x-4x). However, the forward PS of approximately 6.6x, based on analyst revenue estimates of $1.457 billion, implies the market is pricing in tremendous growth and some margin improvement. The valuation implies the market expects Karman to nearly 11x its quarterly revenue run-rate while simultaneously fixing its profitability issues—a very demanding set of expectations that leaves little room for error.
KRMN is a speculative buy only for investors with a very high risk tolerance and a long-term horizon. The 47% revenue growth and exposure to hypersonics are compelling, but these are offset by severe risks: a -$43 million cash burn, a collapsing gross margin, and a valuation that remains rich despite a 37% three-month decline. Analyst consensus is bullish, but the stock's price action suggests deep skepticism. It could be a good buy for aggressive investors if acquired at a lower price point (e.g., below $50) that better reflects these risks, but at current levels, the risk/reward is balanced, warranting a Hold stance for most.
KRMN is strictly a long-term investment for speculative capital, with a suggested minimum holding period of 3-5 years. The company is in a high-investment growth phase, burning cash to build scale, and its value will only be realized if it successfully captures the hypersonics and missile defense market over many years. The stock's extreme volatility (52-week high of $118.38, low of $36.11), high short interest, and lack of a dividend make it unsuitable for short-term trading or income investors. Only investors willing to endure significant drawdowns for potential outsized returns years from now should consider a position.
